Related Experiment Video
Updated: Jan 1, 2026
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Network medicine strikes a blow against breast cancer
1Biotech Research and Innovation Center, University of Copenhagen, Denmark. janine.erler@bric.ku.dk
Abstract:
Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time- and order-dependent drug combinations can be more efficacious in killing cancer cells.
Insights
Targeting complex diseases requires systems-based approaches. A new study shows that combining drugs in a specific sequence can effectively kill triple-negative breast cancer cells by exploiting network vulnerabilities.
Area of Science:
- Oncology
- Systems Biology
- Pharmacology
Background:
- Complex diseases necessitate a shift from single-target therapies to systems-based strategies.
- Drug development is moving towards targeting dynamic biological network states.
- Triple-negative breast cancer (TNBC) remains a challenging disease with limited treatment options.
Discussion:
- The study investigates the dynamic rewiring of signaling networks after epidermal growth factor receptor (EGFR) inhibition in TNBC.
- It reveals how temporal changes in the tumor's signaling network create vulnerabilities.
- The findings highlight the importance of considering the timing and order of drug administration.
Key Insights:
- Progressive rewiring of signaling networks following EGFR inhibition sensitizes TNBC tumors to subsequent treatments.
- A time- and order-dependent drug combination strategy can be more efficacious than single-agent therapy.
- Exploiting network state dynamics offers a novel approach for improving cancer therapy outcomes.
Outlook:
- This research opens new avenues for designing rational, combination therapies in oncology.
- Future studies could explore optimal drug sequencing for various complex diseases.
- The findings may inform the development of next-generation cancer treatments targeting network vulnerabilities.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
